Abstract
A comprehensive two-phase "hot spot" saturation mutagenesis strategy for the rapid evolution of glycosyltransferase (GT) specificity for nonnatural acceptors is described. Specifically, the application of a high-throughput screen (based on the fluorescent acceptor umbelliferone) was used to identify key amino acid hot spots that contribute to GT proficiency and/or promiscuity. Saturation mutagenesis of the corresponding hot spots facilitated the utilization of a lower-throughput screen to provide OleD prodigy capable of efficiently glycosylating the nonnatural acceptor novobiocic acid with an array of unique sugars. Incredibly, even in the absence of a high-throughput screen for novobiocic acid glycosylation, this approach rapidly led to improvements in the desired catalytic activity of several hundred-fold.
Original language | English |
---|---|
Pages (from-to) | 393-401 |
Number of pages | 9 |
Journal | Chemistry and Biology |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Apr 21 2008 |
Bibliographical note
Funding Information:We are grateful to the School of Pharmacy Analytical Instrumentation Center for analytical support. This work was supported in part by National Institutes of Health grants AI52218 and U19 CA113297. J.S.T is a University of Wisconsin H.I. Romnes Fellow. The authors report competing interests. J.S.T. is a cofounder of Centrose (Madison, WI).
Funding
We are grateful to the School of Pharmacy Analytical Instrumentation Center for analytical support. This work was supported in part by National Institutes of Health grants AI52218 and U19 CA113297. J.S.T is a University of Wisconsin H.I. Romnes Fellow. The authors report competing interests. J.S.T. is a cofounder of Centrose (Madison, WI).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | U19 CA113297 |
National Institute of Allergy and Infectious Diseases | R01AI052218 |
Keywords
- CHEMBIO
- PROTEINS
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry